1. Purification of HIV-1 wild-type protease and characterization of proteolytically inactive HIV-1 protease mutants by pepstatin A affinity chromatography
- Author
-
John M. Louis, Ewald M. Wondrak, Stephen Oroszlan, and Peter T. Mora
- Subjects
Proteases ,medicine.medical_treatment ,Molecular Sequence Data ,Biophysics ,Biology ,Pepstatin A affinity chromatography ,Biochemistry ,Chromatography, Affinity ,chemistry.chemical_compound ,HIV Protease ,Affinity chromatography ,HIV-1 protease ,Structural Biology ,Endopeptidases ,Pepstatins ,Escherichia coli ,Genetics ,medicine ,Amino Acid Sequence ,Binding site ,Molecular Biology ,chemistry.chemical_classification ,Protease ,Wild type ,Cell Biology ,Mutant protease ,Molecular biology ,Recombinant Proteins ,Enzyme ,chemistry ,Mutation ,HIV-1 ,biology.protein ,Pepstatin - Abstract
Recombinant wild-type protease of human immunodeficiency virus, type 1 (HIV-1) expressed in E. coli was purified by pepstatin A affinity chromatography. An 88-fold purification was achieved giving a protease preparation with a specific enzymatic activity of approximately 3700 pmol/min/micrograms. Two proteolytically inactive HIV-1 mutant proteases (Arg-87----Lys; Asn-88----Glu) were found to bind to pepstatin A agarose, and and they were purified as the wild-type protease. A third mutant protease Arg-87----Glu) was apparently unable to bind to pepstatin A under similar conditions. Binding to pepstatin A indicates the binding ability of the substrate binding site and the ability to form dimers. These features may be used to purify and to characterize other mutated HIV-1 proteases.
- Published
- 1991
- Full Text
- View/download PDF